PMC:7696151 / 48674-48824 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1408","span":{"begin":50,"end":53},"obj":"Chemical"}],"attributes":[{"id":"A1408","pred":"tao:has_database_id","subj":"1408","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" that a reduction by up to 57% is associated with HCQ maintaining treatment (272 mg/day) [84]. A case-control study was carried out in order to define"}